On the recordSeptember 18, 2014
As members of the committee, we have heard firsthand the urgent need for greater incentives to encourage new drug and diagnostic development in the antibiotic space.
Source
congress.govAs members of the committee, we have heard firsthand the urgent need for greater incentives to encourage new drug and diagnostic development in the antibiotic space.
Leonard Lance highlights the urgent need for incentives in drug development.
Share & report
More from Leonard Lance
I think that would be extremely unfortunate, and that does not really complete the task. And I think the task needs to be completed. Now, of course, a phase 3 would require support from Democratic colleagues, because of the filibuster rule…
I want to thank Congressman Pallone who has worked on this issue over the course of the last more than a decade.